Major depressive disorder (MDD) afflicts millions globally, with conventional treatments often proving limited in success. This has fueled the exploration of alternative therapeutic approaches. Among these, ketamine has emerged as a intriguing candidate for MDD treatment. Ketamine is a hallucinogeni